R. Akehurst

1.4k total citations
34 papers, 1.0k citations indexed

About

R. Akehurst is a scholar working on Economics and Econometrics, Cardiology and Cardiovascular Medicine and Transplantation. According to data from OpenAlex, R. Akehurst has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Economics and Econometrics, 11 papers in Cardiology and Cardiovascular Medicine and 5 papers in Transplantation. Recurrent topics in R. Akehurst's work include Health Systems, Economic Evaluations, Quality of Life (15 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Renal Transplantation Outcomes and Treatments (5 papers). R. Akehurst is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (15 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Renal Transplantation Outcomes and Treatments (5 papers). R. Akehurst collaborates with scholars based in United Kingdom, United States and France. R. Akehurst's co-authors include Stephen J. Walters, J. Chilcott, Eva Kaltenthaler, David R. Holmes, Stacey L. Amorosi, Vivek Y. Reddy, Éric Abadie, Jennifer Burr, Michael P. Kelly and Hazel Squires and has published in prestigious journals such as Journal of the American College of Cardiology, Stroke and Gut.

In The Last Decade

R. Akehurst

33 papers receiving 950 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
R. Akehurst 283 243 222 123 106 34 1.0k
Karen M. Stockl 131 0.5× 165 0.7× 127 0.6× 41 0.3× 89 0.8× 26 854
Kavita V. Nair 97 0.3× 201 0.8× 160 0.7× 8 0.1× 85 0.8× 69 891
Michael S. Nussbaum 192 0.7× 33 0.1× 698 3.1× 106 0.9× 13 0.1× 77 1.4k
James F. Fries 67 0.2× 88 0.4× 144 0.6× 48 0.4× 10 0.1× 12 919
Ann D. Smith 172 0.6× 32 0.1× 256 1.2× 14 0.1× 18 0.2× 29 738
Egon Jonsson 44 0.2× 405 1.7× 260 1.2× 8 0.1× 31 0.3× 60 1.3k
Michele Bellantoni 77 0.3× 33 0.1× 93 0.4× 9 0.1× 38 0.4× 41 1.1k
Antonio Palazón‐Bru 139 0.5× 44 0.2× 167 0.8× 21 0.2× 8 0.1× 105 1.0k
Suela Sulo 97 0.3× 28 0.1× 263 1.2× 12 0.1× 15 0.1× 92 1.4k
LeAnn Michaels 39 0.1× 56 0.2× 195 0.9× 36 0.3× 9 0.1× 37 986

Countries citing papers authored by R. Akehurst

Since Specialization
Citations

This map shows the geographic impact of R. Akehurst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Akehurst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Akehurst more than expected).

Fields of papers citing papers by R. Akehurst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Akehurst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Akehurst. The network helps show where R. Akehurst may publish in the future.

Co-authorship network of co-authors of R. Akehurst

This figure shows the co-authorship network connecting the top 25 collaborators of R. Akehurst. A scholar is included among the top collaborators of R. Akehurst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Akehurst. R. Akehurst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kamae, Isao, Hidehiko Hara, Koichi Inoue, et al.. (2023). Cost-effectiveness of left atrial appendage closure with Watchman for non-valvular atrial fibrillation patients in Japan. Journal of Medical Economics. 26(1). 1357–1367. 3 indexed citations
2.
Solà-Morales, Oriol, et al.. (2022). POSB405 Data Governance for Rwd/E Management: Optimising Its Use in HTA and Decision-Making. Value in Health. 25(1). S260–S260. 1 indexed citations
3.
Akehurst, R., et al.. (2016). Variation in Health Technology Assessment and Reimbursement Processes in Europe. Value in Health. 20(1). 67–76. 89 indexed citations
4.
5.
Squires, Hazel, J. Chilcott, R. Akehurst, Jennifer Burr, & Michael P. Kelly. (2016). A Framework for Developing the Structure of Public Health Economic Models. Value in Health. 19(5). 588–601. 59 indexed citations
6.
Squires, Hazel, J. Chilcott, R. Akehurst, Jennifer Burr, & Michael P. Kelly. (2016). A systematic literature review of the key challenges for developing the structure of public health economic models. International Journal of Public Health. 61(3). 289–298. 27 indexed citations
7.
Tosh, Jonathan, Matt Stevenson, R. Akehurst, & Mark Strong. (2015). Simulation optimisation of Treatment Sequences for Rheumatoid arthritis. Value in Health. 18(7). A343–A343. 2 indexed citations
8.
Reddy, Vivek Y., et al.. (2015). Time to Cost-Effectiveness Following Stroke Reduction Strategies in AF. Journal of the American College of Cardiology. 66(24). 2728–2739. 60 indexed citations
9.
Reddy, Vivek Y., et al.. (2014). COST UTILITY AND QUALITY OF LIFE IMPACT OF LEFT ATRIAL APPENDAGE CLOSURE COMPARED TO WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION. Journal of the American College of Cardiology. 63(12). A353–A353.
10.
11.
12.
Geisler, Benjamin P., Brent M. Egan, Joshua T. Cohen, et al.. (2012). Cost-Effectiveness and Clinical Effectiveness of Catheter-Based Renal Denervation for Resistant Hypertension. Journal of the American College of Cardiology. 60(14). 1271–1277. 109 indexed citations
13.
14.
15.
Karnon, Jonathan, Ameet Bakhai, Alan Brennan, et al.. (2005). A cost-utility analysis of clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes in the UK. International Journal of Cardiology. 109(3). 307–316. 23 indexed citations
16.
Walters, Stephen J., et al.. (2003). Economic Implications of the Use of Basiliximab in Addition to Triple Immunosuppressive Therapy in Renal Allograft Recipients. PharmacoEconomics. 21(2). 129–138. 16 indexed citations
17.
Chilcott, J., Michael Holmes, Stephen J. Walters, R. Akehurst, & Björn Nashan. (2002). The economics of basiliximab (Simulect) in preventing acute rejection in renal transplantation.. PubMed. 15(9-10). 486–93. 16 indexed citations
18.
Akehurst, R., et al.. (2001). Treatment of irritable bowel syndrome: a review of randomised controlled trials. Gut. 48(2). 272–282. 141 indexed citations
19.
Walters, Stephen J., Michael G. Whitfield, R. Akehurst, & J. Chilcott. (2001). Pharmacoeconomic evaluation of simulect prophylaxis in renal transplant recipients. Transplantation Proceedings. 33(7-8). 3187–3191. 12 indexed citations
20.
Akehurst, R., et al.. (1998). New therapeutic products and difficult decisions. The case of recombinant factor VIII in the management of haemophilia A. Journal of Public Health. 20(2). 137–138. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen M. Stockl Breakdown of academic impact, for papers by Kavita V. Nair Breakdown of academic impact, for papers by Michael S. Nussbaum Breakdown of academic impact, for papers by James F. Fries Breakdown of academic impact, for papers by Ann D. Smith Breakdown of academic impact, for papers by Egon Jonsson Breakdown of academic impact, for papers by Michele Bellantoni Breakdown of academic impact, for papers by Antonio Palazón‐Bru Breakdown of academic impact, for papers by Suela Sulo Breakdown of academic impact, for papers by LeAnn Michaels
Rankless by CCL
2026